Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

348 Views

Z4. COVID-19 Treatment

Poster Session: COVID-19: Treatment

(P-2035) Pharmacokinetics (PK) and Serum Virus Neutralizing Antibody (sVNA) Titers Following the 2^nd dose of Pemivibart in the Phase 3 CANOPY Trial

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

Anna Holmes, PhD

Principal Clinical Scientist
Invivyd, Inc.
Waltham, MA, United States
YL

Yong Li, PhD

Invivyd, Inc.
Waltham, Massachusetts, United States
DG

Deepali Gupta, BSc

Invivyd, Inc.
Waltham, Massachusetts, United States
CK

Chloe Katz, PMP

Invivyd, Inc.
Waltham, Massachusetts, United States
MG

Mike Gavazzi, B.S.

Invivyd, Inc.
Waltham, Massachusetts, United States

Presenting Author(s)

PH

Pamela Hawn, Pharm.D.

Senior Director, Medical Affairs
Invivyd, Inc.
Waltham, Massachusetts, United States

Co-Author(s)

Kathryn Mahoney, PharmD

Associate Director, Clinical Research
Invivyd, Inc.
Waltham, Massachusetts, United States

Co-Author(s)

MP

Myra Popejoy, Pharm.D.

Invivyd, Inc.
Waltham, Massachusetts, United States